Myocardial Ischemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Cardioplegia prevents ischemia-induced transcriptional alterations of cytoprotective genes in rat hearts: a DNA microarray study.
|
16214533 |
2005 |
Age at menarche
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Bipolar Disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis.
|
27890468 |
2017 |
Attention deficit hyperactivity disorder
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis.
|
27890468 |
2017 |
Age at menarche
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Detection and interpretation of shared genetic influences on 42 human traits.
|
27182965 |
2016 |
Age at menarche
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.
|
25231870 |
2014 |
Personality Traits
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Genome-wide association study of personality traits in bipolar patients.
|
21368711 |
2011 |
Personality Traits
|
0.100 |
GeneticVariation
|
group |
GWASDB |
Genome-wide association study of personality traits in bipolar patients.
|
21368711 |
2011 |
Age at menarche
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies.
|
21102462 |
2010 |
Age at menarche
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies.
|
21102462 |
2010 |
Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
Nuclear RXRG expression was significantly associated with smaller tumour size (p = 0.036), lower grade (p < 0.001), lobular histology (p = 0.016), lower Nottingham Prognostic Index (p = 0.04) and longer breast cancer-specific survival (p < 0.001), and longer time to distant metastasis (p = 0.002).
|
31558802 |
2019 |
Neoplasms
|
0.040 |
PosttranslationalModification
|
group |
BEFREE |
RXRG-methylation(+) significantly associated with better prognosis when analyzing all tumor cases (P = 0.04), and when analyzing the p16-negative poorer-outcome group (P = 0.03).
|
28823962 |
2017 |
Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
The RXRγ mRNA expression, as well as extrathyroid invasion, LOP/C and advanced tumor stage, was further confirmed to be one of the independent predictive factors (Odds ratio: 6.545; 95% confidence interval: 1.575-27.208) of LNM using multivariate analysis.
|
21355951 |
2011 |
Neoplasms
|
0.040 |
AlteredExpression
|
group |
BEFREE |
A significant correlation was observed between the expression of retinoid X receptor gamma and tumor stage, distant metastasis or the 5-year cancer specific survival rate.
|
17707062 |
2007 |
Neoplasm Metastasis
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
Nuclear RXRG expression was significantly associated with smaller tumour size (p = 0.036), lower grade (p < 0.001), lobular histology (p = 0.016), lower Nottingham Prognostic Index (p = 0.04) and longer breast cancer-specific survival (p < 0.001), and longer time to distant metastasis (p = 0.002).
|
31558802 |
2019 |
Neoplasm Metastasis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
These results suggest that RXRγ may play a role in the dedifferentiation and metastasis of PTC.
|
21355951 |
2011 |
Neoplasm Metastasis
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
In contrast, retinoid X receptor gamma expression correlated significantly with tumor stage (p = 0.009) and distant metastasis (p = 0.005).
|
17707062 |
2007 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Association between Single-nucleotide Polymorphisms of RXRG and Genetic Susceptibility to Type 2 Diabetes in South China.
|
31808386 |
2019 |
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Multivariate analysis demonstrated RXRG protein as an independent predictor of longer breast cancer-specific survival and distant metastasis-free survival.
|
31558802 |
2019 |
Breast Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
We investigated the effects of epigallocatechin-3-gallate (EGCG), the most active green tea catechin, in combination with 6-OH-11-O-hydroxyphenanthrene (IIF), a synthetic retinoid X receptor-γ (RXRγ) agonist, on three breast carcinoma cell lines: MCF-7, MCF-7TAM and MDA-MB-231.
|
28465354 |
2017 |
Carcinogenesis
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
This finding suggests that methylation-associated downregulation of the RXRG gene may play a differential role in the carcinogenesis of NSCLCs according to smoking status, but further studies are needed to confirm this.
|
20113835 |
2010 |
Carcinogenesis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Our observations suggest that alterations of vitamin D receptor and retinoid X receptor expression may be involved in renal carcinogenesis and retinoid X receptor gamma expression may be a useful prognostic marker in patients with renal cell carcinoma.
|
17707062 |
2007 |
Diabetes Mellitus, Non-Insulin-Dependent
|
0.020 |
Biomarker
|
disease |
BEFREE |
These data suggest that RXRgamma may contribute to disordered lipid metabolism in members of familial T2DM kindreds, but this gene is unlikely to explain the linkage of T2DM with this region.
|
12175776 |
2002 |
Malignant neoplasm of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
Multivariate analysis demonstrated RXRG protein as an independent predictor of longer breast cancer-specific survival and distant metastasis-free survival.
|
31558802 |
2019 |
Invasive carcinoma of breast
|
0.010 |
Biomarker
|
disease |
BEFREE |
Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer.
|
31558802 |
2019 |